The market for stem cell manufacturing is estimated to increase rapidly over the forecast period. Some stem cell-based treatments, such as hematopoietic stem cell transplants for leukaemia and epithelial stem cell-based treatments for burns and corneal diseases, have become clinical standards of care. In recent years, advances in stem cell research have broadened the spectrum of prospective stem cell-based therapeutics. People with spinal cord injuries, type 1 diabetes, amyotrophic lateral sclerosis, cancer, Alzheimer's disease, stroke, burns, heart disease, osteoarthritis and Parkinson's disease may benefit from stem cell therapy. They could be utilized to replace cells and tissues that have been damaged or destroyed due to disease in the future.
